文献速递肝病消化道肿瘤与早癌

脂肪性肝炎损害小鼠体内T细胞导向的肝脏肿瘤免疫治疗疗效

Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice.
PubMed 文献 · Gastroenterology · 2020-10-01

研究在喂食蛋氨酸胆碱缺乏饮食或胆碱缺乏L-氨基酸限定饮食诱导脂肪性肝炎的小鼠中,观察M30-RNA疫苗和抗OX40抗体对肝内或皮下接种B16黑色素瘤及CT26结肠癌细胞生长的影响。结果显示脂肪性肝炎小鼠中M30和/或aOX40不能减缓肝肿瘤生长,但皮下肿瘤不受影响;N-乙酰半胱氨酸可恢复CD4+ T细胞数量并恢复疗效。

要点

  • 脂肪性肝炎小鼠中M30和/或aOX40不能减缓肝内B16或CT26肿瘤生长。
  • 脂肪性肝炎不影响M30减缓皮下B16肿瘤生长的能力。
  • N-乙酰半胱氨酸可恢复脂肪性肝炎小鼠中M30和aOX40减缓肝肿瘤生长的能力。

核心结论

  • 脂肪性肝炎通过减少肿瘤内CD4+ T细胞和效应记忆细胞浸润,降低M30和aOX40抑制小鼠肝肿瘤生长的能力。
  • N-乙酰半胱氨酸可恢复肿瘤内T细胞数量并增强M30和aOX40减缓肿瘤生长的能力。

研究设计与样本

  • 研究为小鼠实验,使用C57BL/6NCrl或BALB/c AnNCr小鼠,通过喂食蛋氨酸胆碱缺乏饮食或胆碱缺乏L-氨基酸限定饮食诱导脂肪性肝炎。
  • 小鼠接受肝内或皮下注射B16黑色素瘤和CT26结肠癌细胞,随后在注射肿瘤细胞后第3、7、10天静脉注射M30-RNA疫苗(M30)或腹腔注射抗OX40抗体(aOX40)。
  • 通过测量肿瘤生长和流式细胞术分析肿瘤组织中免疫细胞。
  • 部分小鼠给予N-乙酰半胱氨酸以预防肝脏CD4+ T细胞丢失。

主要发现

  • 在常规饮食小鼠中,给予M30和aOX40可抑制肝内注射B16或CT26细胞形成的肿瘤生长。
  • 在饮食诱导脂肪性肝炎小鼠中,M30和/或aOX40未能减缓肝内B16或CT26细胞形成的肿瘤生长。
  • 脂肪性肝炎不影响M30减缓皮下B16肿瘤生长的能力。
  • 在给予N-乙酰半胱氨酸的脂肪性肝炎小鼠中,M30和aOX40能够减缓肝肿瘤生长。
  • 流式细胞术分析显示,与无脂肪性肝炎小鼠相比,脂肪性肝炎小鼠肝肿瘤中CD4+ T细胞和效应记忆细胞减少。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Nonalcoholic steatohepatitis causes loss of hepatic CD4+ T cells and promotes tumor growth. The liver is the most common site of distant metastases from a variety of malignancies, many of which respond to immunotherapy. We investigated the effects of steatohepatitis on the efficacy of immunotherapeutic agents against liver tumors in mice. METHODS: Steatohepatitis was induced by feeding C57BL/6NCrl or BALB/c AnNCr mice a methionine and choline-deficient diet or a choline-deficient l-amino acid-defined diet. Mice were given intrahepatic or subcutaneous injections of B16 melanoma and CT26 colon cancer cells, followed by intravenous injections of M30-RNA vaccine (M30) or intraperitoneal injections of an antibody against OX40 (aOX40) on days 3, 7, and 10 after injection of the tumor cells. We measured tumor growth and analyzed immune cells in tumor tissues by flow cytometry. Mice were given N-acetylcysteine to prevent loss of CD4+ T cells from liver. RESULTS: Administration of M30 and aOX40 inhibited growth of tumors from intrahepatic injections of B16 or CT26 cells in mice on regular diet. However, M30 and/or aOX40 did not slow growth of liver tumors from B16 or CT26 cells in mice with diet-induced steatohepatitis (methionine and choline-deficient diet or choline-deficient l-amino acid-defined diet). Steatohepatitis did not affect the ability of M30 to slow growth of subcutaneous B16 tumors. In mice with steatohepatitis given N-acetylcysteine, which prevents loss of CD4+ T cells, M30 and aOX40 were able slow growth of hepatic tumors. Flow cytometry analysis of liver tumors revealed reduced CD4+ T cells and effector memory cells in mice with vs without steatohepatitis. CONCLUSIONS: Steatohepatitis reduces the abilities of immunotherapeutic agents, such as M30 and aOX40, to inhibit tumor liver growth by reducing tumor infiltration by CD4+ T cells and effector memory cells. N-acetylcysteine restores T-cell numbers in tumors and increases the ability of M30 and aOX40 to slow tumor growth in mice.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Heinrich B, Brown ZJ, Diggs LP, et al. Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice. Gastroenterology. 2020. PMID: 33010248. doi:10.1053/j.gastro.2020.09.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。